Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.40 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20710063 | 0.97 | DNM1 (0.57) | DNM1ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL3626123 | 0.97 | DNM1 (0.57) | DNM1ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL19103054 | 0.97 | DNM1 (0.57) | DNM1ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL3624962 | 0.97 | DNM1 (0.57) | DNM1ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL3626321 | 0.95 | DNM1 (0.60) | DNM1ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL24107253 | 0.92 | DNM1 (0.65) | DNM1ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL20017999 | 0.92 | DNM1 (0.65) | DNM1ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL3620472 | 0.92 | DNM1 (0.65) | DNM1ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL3622910 | 0.92 | DNM1 (0.65) | DNM1ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL1688008 | 0.92 | DNM1 (0.65) | DNM1ALDH1A1MEN1KMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12246000-B2 | Inhibition of protein amyloid aggregation using fluorinated benzenesulfonamides | VILNIUS UNIVERSITY (LT) | 2025-03-11 | — | — | US | disclosed |
| WO-2024015340-A1 | CEREBLON LIGANDS AND USES THEREOF | REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2024-01-18 | — | — | WO | disclosed |
| US-20240000736-A1 | INHIBITION OF PROTEIN AMYLOID AGGREGATION USING FLUORINATED BENZENESULFONAMIDES | VILNIUS UNIVERSITY (LT) | 2024-01-04 | — | — | US | disclosed |
| EP-4299062-A1 | INHIBITION OF PROTEIN AMYLOID AGGREGATION USING FLUORINATED BENZENESULFONAMIDES | Vilnius University (LT) | 2024-01-03 | — | — | EP | disclosed |
| WO-2023183607-A1 | CEREBLON LIGANDS AND USES THEREOF | REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2023-09-28 | — | — | WO | disclosed |
| US-11124498-B2 | Compositions and methods for modulating protease activity | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-09-21 | — | — | US | disclosed |
| EP-3397615-B1 | MIXED DECYL MERCAPTANS COMPOSITIONS AND METHODS OF MAKING SAME | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2021-08-18 | — | — | EP | disclosed |
| US-20210202360-A1 | SEMICONDUCTOR PACKAGE DEVICE WITH INTEGRATED INDUCTOR AND MANUFACTURING METHOD THEREOF | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD. (TW) | 2021-07-01 | — | — | US | disclosed |
| WO-2020206034-A1 | CELL CYCLE INHIBITING COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS | G1 THERAPEUTICS, INC. (US) | 2020-10-08 | — | — | WO | disclosed |
| US-20200048227-A1 | COMPOSITIONS AND METHODS FOR MODULATING PROTEASE ACTIVITY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2020-02-13 | — | — | US | disclosed |
| CN-105273724-B | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | 奇美实业股份有限公司 | 2017-07-14 | — | — | CN | disclosed |
| CN-106947499-A | Liquid crystal alignment agent and application thereof | 奇美实业股份有限公司 | 2017-07-14 | — | — | CN | disclosed |
| CN-106497576-A | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | 奇美实业股份有限公司 | 2017-03-15 | — | — | CN | disclosed |
| CN-101576687-B | Liquid crystal aligning agent and method for producing liquid crystal alignment film formed by using the same | CHI MEI IND CO LTD | 2011-07-20 | — | — | CN | disclosed |
| CN-101614912-B | Liquid crystal aligning agent and method for producing liquid crystal alignment film formed by using the same | CHIMEI CORP | 2011-01-05 | — | — | CN | disclosed |
| CN-101614912-A | Liquid crystal aligning agent and method for producing liquid crystal alignment film formed by using the same | CHIMEI CORP | 2009-12-30 | — | — | CN | disclosed |
| CN-101576687-A | Liquid crystal aligning agent and method for producing liquid crystal alignment film formed by using the same | CHIMEI CORP (CN) | 2009-11-11 | — | — | CN | disclosed |
| US-20080125552-A1 | Low-Viscosity Microcapsule Dispersions | BASF AKTIENGESELLSCHAFT PATENTS, TRADEMARKS AND LICENSES (DE) | 2008-05-29 | — | — | US | disclosed |
| US-20080103265-A1 | Microcapsule Dispersions | BASF AKTIENGESELLSCHAFT (DE) | 2008-05-01 | — | — | US | disclosed |
| EP-0106138-B1 | CONTINUOUS PROCESS FOR THE HOT PHOSGENATION OF AMINES | HÜLS AKTIENGESELLSCHAFT (DE) | 1985-07-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240000736-A1 | INHIBITION OF PROTEIN AMYLOID AGGREGATION USING FLUORINATED BENZENESULFONAMIDES | APP, APBA1, IAPP | DNM1 1983/4885ALDH1A1 3244/4885MEN1 1754/4885 |
| US-11124498-B2 | Compositions and methods for modulating protease activity | RNASE1, ADAM8, CTRL | DNM1 1576/4885ALDH1A1 3631/4885MEN1 3690/4885 |
| US-20200048227-A1 | COMPOSITIONS AND METHODS FOR MODULATING PROTEASE ACTIVITY | RNASE1, ADAM8, CTRL | DNM1 1576/4885ALDH1A1 3631/4885MEN1 3690/4885 |
| US-12246000-B2 | Inhibition of protein amyloid aggregation using fluorinated benzenesulfonamides | APP, APBA1, IAPP | DNM1 1983/4885ALDH1A1 3244/4885MEN1 1754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.